![](/img/cover-not-exists.png)
Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration
Heyward, James, Olson, Lily, Sharfstein, Joshua M., Stuart, Elizabeth A., Lurie, Peter, Alexander, G. CalebJournal:
JAMA Internal Medicine
DOI:
10.1001/jamainternmed.2019.5459
Date:
December, 2019
File:
PDF, 225 KB
2019